Diana McKenzie

CIK: 0001754648

Transaction Breakdown

Open Market Buys (P)2 (7.7%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)22 (84.6%)

Compensation grants

Other (G, F, J, C, D, …)2 (7.7%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (3)

MET

METLIFE INC

Director

AGL

agilon health, inc.

Director

VRTX

VERTEX PHARMACEUTICALS INC / MA

Director

Discretionary Trading P&L

Holdings

Transaction History (26 total)

MET
METLIFE INC
Oct 1, 2026
Award(A)
Direct
544 shares at avg. $94.35$51K
MET
METLIFE INC
Sep 8, 2026
Award(A)
Direct
157 shares at avg. $95.50$15K
MET
METLIFE INC
Jun 16, 2026
Award(A)
Direct
587 shares at avg. $87.40$51K
MET
METLIFE INC
Jun 9, 2026
Award(A)
Direct
169 shares at avg. $85.57$14K
AGL
agilon health, inc.
Jun 2, 2026
Award(A)
Direct
2.1K shares-
VRTX
VERTEX PHARMACEUTICALS INC / MA
May 1, 2026
Award(A)
Direct
943 shares-
VRTX
VERTEX PHARMACEUTICALS INC / MA
May 1, 2026
Disposition(D)
Direct
796 shares-
MET
METLIFE INC
Apr 1, 2026
Award(A)
Direct
721 shares at avg. $71.17$51K
MET
METLIFE INC
Mar 10, 2026
Award(A)
Direct
189 shares at avg. $70.60$13K
MET
METLIFE INC
Jan 2, 2026
Award(A)
Direct
639 shares at avg. $80.32$51K
MET
METLIFE INC
Dec 9, 2025
Award(A)
Direct
166 shares at avg. $77.82$13K
MET
METLIFE INC
Oct 1, 2025
Award(A)
Direct
534 shares at avg. $81.93$44K
MET
METLIFE INC
Sep 9, 2025
Award(A)
Direct
158 shares at avg. $79.29$13K
MET
METLIFE INC
Jun 17, 2025
Award(A)
Direct
562 shares at avg. $77.85$44K
MET
METLIFE INC
Jun 10, 2025
Award(A)
Direct
153 shares at avg. $79.43$12K
AGL
agilon health, inc.
May 28, 2025
Award(A)
Direct
78.7K shares-
VRTX
VERTEX PHARMACEUTICALS INC / MA
May 1, 2025
Award(A)
Direct
796 shares-
VRTX
VERTEX PHARMACEUTICALS INC / MA
May 1, 2025
Disposition(D)
Direct
1K shares-
MET
METLIFE INC
Apr 1, 2025
Award(A)
Direct
540 shares at avg. $81.16$44K
MET
METLIFE INC
Mar 11, 2025
Award(A)
Direct
144 shares at avg. $78.45$11K
MET
METLIFE INC
Jan 2, 2025
Award(A)
Direct
535 shares at avg. $81.78$44K
MET
METLIFE INC
Dec 16, 2024
Award(A)
Direct
132 shares at avg. $82.74$11K
AGL
agilon health, inc.
Dec 9, 2024
Purchase(P)
Direct
7.5K shares at avg. $2.20$16K
AGL
agilon health, inc.
Nov 25, 2024
Purchase(P)
Direct
12.5K shares at avg. $2.28$28K
MET
METLIFE INC
Oct 1, 2024
Award(A)
Direct
535 shares at avg. $81.78$44K

		Type	Shares	Price		Ownership
Oct 1, 2026	MET METLIFE INC	Award(A)	544	$94.35	$51,326	Direct
Sep 8, 2026	MET METLIFE INC	Award(A)	157	$95.50	$14,994	Direct
Jun 16, 2026	MET METLIFE INC	Award(A)	587	$87.40	$51,304	Direct
Jun 9, 2026	MET METLIFE INC	Award(A)	169	$85.57	$14,461	Direct
Jun 2, 2026	AGL agilon health, inc.	Award(A)	2,133	-	$0	Direct
May 1, 2026	VRTX VERTEX PHARMACEUTICALS INC / MA	Award(A)	943	-	$0	Direct
May 1, 2026	VRTX VERTEX PHARMACEUTICALS INC / MA	Disposition(D)	796	-	$0	Direct
Apr 1, 2026	MET METLIFE INC	Award(A)	721	$71.17	$51,314	Direct
Mar 10, 2026	MET METLIFE INC	Award(A)	189	$70.60	$13,343	Direct
Jan 2, 2026	MET METLIFE INC	Award(A)	639	$80.32	$51,324	Direct
Dec 9, 2025	MET METLIFE INC	Award(A)	166	$77.82	$12,918	Direct
Oct 1, 2025	MET METLIFE INC	Award(A)	534	$81.93	$43,751	Direct
Sep 9, 2025	MET METLIFE INC	Award(A)	158	$79.29	$12,528	Direct
Jun 17, 2025	MET METLIFE INC	Award(A)	562	$77.85	$43,752	Direct
Jun 10, 2025	MET METLIFE INC	Award(A)	153	$79.43	$12,153	Direct
May 28, 2025	AGL agilon health, inc.	Award(A)	78,724	-	-	Direct
May 1, 2025	VRTX VERTEX PHARMACEUTICALS INC / MA	Award(A)	796	-	-	Direct
May 1, 2025	VRTX VERTEX PHARMACEUTICALS INC / MA	Disposition(D)	1,001	-	-	Direct
Apr 1, 2025	MET METLIFE INC	Award(A)	540	$81.16	$43,826	Direct
Mar 11, 2025	MET METLIFE INC	Award(A)	144	$78.45	$11,297	Direct
Jan 2, 2025	MET METLIFE INC	Award(A)	535	$81.78	$43,752	Direct
Dec 16, 2024	MET METLIFE INC	Award(A)	132	$82.74	$10,922	Direct
Dec 9, 2024	AGL agilon health, inc.	Purchase(P)	7,500	$2.20	$16,489	Direct
Nov 25, 2024	AGL agilon health, inc.	Purchase(P)	12,500	$2.28	$28,474	Direct
Oct 1, 2024	MET METLIFE INC	Award(A)	535	$81.78	$43,752	Direct

1-25 of 26 transactions

About MCKENZIE DIANA

MCKENZIE DIANA (SEC CIK 0001754648) files insider reports with the SEC as Director of METLIFE INC (MET), Director of agilon health, inc. (AGL) and Director of VERTEX PHARMACEUTICALS INC / MA (VRTX).

Signal8 holds 23 ownership filings by MCKENZIE DIANA, all Form 4s, filed between Sep 12, 2024 and Oct 5, 2026. Those filings report 26 transactions, from Sep 10, 2024 to Oct 1, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on MCKENZIE DIANA's filings is in NEW YORK, NY.

Recent filings by MCKENZIE DIANA

Oct 1, 2026: Grant or award of MET shares (Form 4, code A).
Sep 8, 2026: Grant or award of MET shares (Form 4, code A).
Jun 16, 2026: Grant or award of MET shares (Form 4, code A).
Jun 9, 2026: Grant or award of MET shares (Form 4, code A).
Jun 2, 2026: Grant or award of AGL shares (Form 4, code A).

Other insiders filing for METLIFE INC (MET)

Johnson Jeh C., Director
HUBBARD ROBERT GLENN, Director
Mumenthaler Christian Stephane, Director
Harris Carla A, Director
WEINBERGER MARK A, Director
Seitz Michelle, Director

How to read Form 4 transaction codes